Tempus AI, Inc. $TEM Shares Acquired by New York State Common Retirement Fund

New York State Common Retirement Fund boosted its stake in shares of Tempus AI, Inc. (NASDAQ:TEM) by 38.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 45,800 shares of the company’s stock after purchasing an additional 12,800 shares during the period. New York State Common Retirement Fund’s holdings in Tempus AI were worth $3,697,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in TEM. Global Retirement Partners LLC grew its holdings in shares of Tempus AI by 29.5% during the third quarter. Global Retirement Partners LLC now owns 733 shares of the company’s stock valued at $59,000 after buying an additional 167 shares during the last quarter. China Universal Asset Management Co. Ltd. lifted its position in Tempus AI by 0.7% during the 2nd quarter. China Universal Asset Management Co. Ltd. now owns 33,757 shares of the company’s stock worth $2,145,000 after acquiring an additional 226 shares during the period. Wealth Enhancement Advisory Services LLC lifted its position in Tempus AI by 2.6% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 9,929 shares of the company’s stock worth $801,000 after acquiring an additional 248 shares during the period. PNC Financial Services Group Inc. grew its stake in Tempus AI by 6.1% during the 2nd quarter. PNC Financial Services Group Inc. now owns 5,003 shares of the company’s stock valued at $318,000 after purchasing an additional 287 shares during the last quarter. Finally, PFG Investments LLC increased its holdings in shares of Tempus AI by 8.5% in the third quarter. PFG Investments LLC now owns 3,830 shares of the company’s stock valued at $309,000 after purchasing an additional 300 shares during the period. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the company. TD Cowen lowered Tempus AI from a “buy” rating to a “hold” rating in a research report on Tuesday, October 21st. Piper Sandler dropped their price objective on shares of Tempus AI from $105.00 to $80.00 and set a “neutral” rating on the stock in a report on Tuesday, November 11th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Tempus AI in a research note on Thursday, January 22nd. JPMorgan Chase & Co. decreased their target price on shares of Tempus AI from $85.00 to $80.00 and set a “neutral” rating for the company in a research report on Monday, December 15th. Finally, Canaccord Genuity Group lowered their price target on shares of Tempus AI from $95.00 to $80.00 and set a “buy” rating on the stock in a report on Monday, December 22nd. Six analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $87.20.

Tempus AI Stock Up 4.7%

Tempus AI stock opened at $54.91 on Friday. The company has a debt-to-equity ratio of 2.45, a current ratio of 3.28 and a quick ratio of 3.12. The stock has a market capitalization of $9.77 billion, a PE ratio of -46.14 and a beta of 5.22. The business has a 50 day simple moving average of $66.36 and a 200-day simple moving average of $73.84. Tempus AI, Inc. has a 12 month low of $36.22 and a 12 month high of $104.32.

Insider Transactions at Tempus AI

In other Tempus AI news, EVP Andrew Polovin sold 12,874 shares of the firm’s stock in a transaction on Monday, November 24th. The stock was sold at an average price of $75.00, for a total value of $965,550.00. Following the transaction, the executive vice president owned 107,590 shares in the company, valued at approximately $8,069,250. This trade represents a 10.69% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Ryan Fukushima sold 10,099 shares of Tempus AI stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $65.54, for a total transaction of $661,888.46. Following the sale, the chief operating officer directly owned 829,081 shares in the company, valued at approximately $54,337,968.74. This trade represents a 1.20% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 761,582 shares of company stock worth $51,997,831. 26.27% of the stock is owned by insiders.

Tempus AI Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.